311 related articles for article (PubMed ID: 34336833)
1. SUMO and SUMOylation Pathway at the Forefront of Host Immune Response.
K ST; Joshi G; Arya P; Mahajan V; Chaturvedi A; Mishra RK
Front Cell Dev Biol; 2021; 9():681057. PubMed ID: 34336833
[TBL] [Abstract][Full Text] [Related]
2. SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.
Liu Y; Zheng Z; Shu B; Meng J; Zhang Y; Zheng C; Ke X; Gong P; Hu Q; Wang H
J Virol; 2016 Dec; 90(23):10472-10485. PubMed ID: 27630238
[TBL] [Abstract][Full Text] [Related]
3. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
[TBL] [Abstract][Full Text] [Related]
4. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
6. Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways.
Wimmer P; Schreiner S
Viruses; 2015 Aug; 7(9):4854-72. PubMed ID: 26343706
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in cellulae methods for determining the target protein SUMOylation.
T K S; Panda AK; Kawadkar J; Bindra D; Joshi PA; Joshi G; Singh HV; Mishra RK
Methods Enzymol; 2022; 675():397-424. PubMed ID: 36220279
[TBL] [Abstract][Full Text] [Related]
8. Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system.
Imbert F; Langford D
J Neurovirol; 2021 Aug; 27(4):531-541. PubMed ID: 34342851
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
Sohn SY; Hearing P
mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.
Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC
J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681
[TBL] [Abstract][Full Text] [Related]
11. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
[TBL] [Abstract][Full Text] [Related]
12. SUMO-SIM interactions: From structure to biological functions.
Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
[TBL] [Abstract][Full Text] [Related]
13. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection.
Gan J; Qiao N; Strahan R; Zhu C; Liu L; Verma SC; Wei F; Cai Q
Rev Med Virol; 2016 Nov; 26(6):435-445. PubMed ID: 27550835
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk between SUMOylation and immune system in host-pathogen interactions.
Zhu G; Tong N; Zhu Y; Wang L; Wang Q
Crit Rev Microbiol; 2024 Apr; ():1-23. PubMed ID: 38619159
[TBL] [Abstract][Full Text] [Related]
17. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
18. SUMO: From Bench to Bedside.
Chang HM; Yeh ETH
Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
[TBL] [Abstract][Full Text] [Related]
19. SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.
Chen AJ; Gao L; Wang XW; Zhao XF; Wang JX
J Virol; 2013 Jan; 87(1):636-47. PubMed ID: 23097446
[TBL] [Abstract][Full Text] [Related]
20. Progress of small ubiquitin-related modifiers in kidney diseases.
Li O; Ma Q; Li F; Cai GY; Chen XM; Hong Q
Chin Med J (Engl); 2019 Feb; 132(4):466-473. PubMed ID: 30707172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
